Semaglutide is gaining traction as a novel treatment for type 2 diabetes. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and reducing https://oisitxmn486864.blog5.net/81011025/grasping-semaglutide-a-comprehensive-guide